Public Release: 

Discovery Of Cellular "Suicide Weapon" Opens Way To Control Of Autoimmune Disorders

American Committee for the Weizmann Institute of Science


Friday, June 14, 1996**

Understanding of brain development and cancer growth also advanced

REHOVOT, ISRAEL -- June 14, 1996...A key enzyme that acts as a "suicide weapon" causing cells to self-destruct has been discovered by Weizmann Institute researchers. This finding, reported in the June 14 issue of Cell, may help in the design of treatments for autoimmune disorders caused by abnormal cellular self-destruction, such as juvenile diabetes and multiple sclerosis. It also advances the understanding of a variety of other normal and abnormal processes involving cell suicide.

"We've identified a crucial step in the self-annihilation of cells and may now be able to control this process," says Prof. David Wallach of the Institute's Department of Membrane Research and Biophysics, whose research team included graduate students Mark Boldin, Tanya Goncharov and Yury Goltsev.

Our body's cells commit suicide regularly in a normal process that enables organs to renew and repair themselves. But in certain autoimmune diseases, the immune system erroneously commands healthy cells to exterminate themselves. Scientists have known for several years that in these disorders certain cells receive the self-destruct message through three receptor molecules on their surface, known as Fas/Apo-1 and two tumor necrosis factor (TNF) receptors.

Now Institute researchers have discovered the "suicide weapon" that translates this message into action -- an enzyme they called MACH. This enzyme cuts up certain vital proteins inside the cell, thereby disrupting its normal functions and causing it to die. The scientists also found that the transmission of the suicide message is surprisingly direct. Unlike many other cellular processes that involve multiple stages and messengers, it is relayed directly from the receptor to the suicide machinery inside the cell.

"We were amazed to discover how little it takes to trigger cellular self-destruction -- it's as if cells always live on the brink of suicide," Wallach said.

The new understanding of the suicide mechanism may make it possible to block it in autoimmune disorders. Moreover, since the death signals are primarily transmitted via Fas/Apo-1 and TNF in the case of disease, it may be possible to selectively block only these abnormal signals while allowing other cell suicide processes to continue in tissues where they are needed. The discovery of the MACH molecule also advances our understanding of the development of the brain and other organs because this enzyme belongs to a family of proteins that play a crucial role in cellular self-destruction involved in these and numerous other body processes. In addition, the new finding may help us understand the growth of cancerous tumors, in which the cellular suicide mechanisms responsible for maintaining the normal growth of tissues are sometimes disturbed. Prof. Wallach has studied TNF receptors for some 14 years and -- together with his Weizmann Institute colleagues -- was among the first researchers in the world to clone them. This research was supported in part by Inter-Lab, Nes Ziona, Israel; Ares Trading S.A., Switzerland, and Israel's Ministry of Science and the Arts. The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,400 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of the human condition. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high priorities.

Prof. David Wallach may be reached at the Weizmann Institute of Science in Rehovot, Israel, 7 hours ahead of New York by phone at:
011 972 8934 3941 lab
011 972 8934 2789 lab
011 972 8946 3302 home

CONTACT: Julie Osler, Director of Public Affairs,
American Committee for the Weizmann Institute of Science
(212) 779-2500
(212) 779-3209 FAX

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.